|
Market Cap (19-May) $36,803,800 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (5-May) 630,735 (0.15%) (400th) |
|
52w High $0.130 |
52w Low $0.086 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 30 October 2020, 11:46. The announcement is not marked as price sensitive, and is 14 page(s) in length and 173kb in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 3.699% short sold according to ASIC data. It was ranked the 60th most shorted stock on the ASX. It remains ranked 400th as of the latest reported data (05 May 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Appendix 2A | 30 October 2020, 11:46 |
| Quarterly Cashflow and Activities Report | 30 October 2020, 9:30 |
| Completion of Placement and SPP raises $48.9M in total | 29 October 2020, 11:16 |
| Starpharma receives $5.7M R&D tax incentive refund | 21 October 2020, 9:17 |
You must be logged in to post a reply.
Starpharma Holdings 